IRIS
SAITTA, Carlo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.417
NA - Nord America 5.971
AS - Asia 2.944
SA - Sud America 855
Continente sconosciuto - Info sul continente non disponibili 270
AF - Africa 117
OC - Oceania 13
Totale 16.587
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.837
RU - Federazione Russa 3.373
SG - Singapore 1.156
CN - Cina 898
BR - Brasile 730
IE - Irlanda 691
IT - Italia 562
SE - Svezia 555
HK - Hong Kong 296
DE - Germania 271
PL - Polonia 237
VN - Vietnam 181
FR - Francia 165
FI - Finlandia 146
GB - Regno Unito 128
IN - India 106
UA - Ucraina 101
BD - Bangladesh 65
CA - Canada 59
AR - Argentina 46
MX - Messico 40
BE - Belgio 37
NL - Olanda 35
ZA - Sudafrica 31
AT - Austria 28
ID - Indonesia 28
TR - Turchia 28
PK - Pakistan 23
CI - Costa d'Avorio 22
JP - Giappone 21
CZ - Repubblica Ceca 20
UZ - Uzbekistan 20
IQ - Iraq 19
MA - Marocco 18
EC - Ecuador 17
ES - Italia 17
CO - Colombia 15
AE - Emirati Arabi Uniti 14
VE - Venezuela 12
JM - Giamaica 11
PH - Filippine 11
PY - Paraguay 10
SA - Arabia Saudita 10
JO - Giordania 9
KE - Kenya 9
MY - Malesia 9
EG - Egitto 8
CH - Svizzera 7
CL - Cile 7
DZ - Algeria 7
EE - Estonia 7
IL - Israele 7
NZ - Nuova Zelanda 7
TN - Tunisia 7
UY - Uruguay 7
BO - Bolivia 6
CR - Costa Rica 6
NP - Nepal 6
AL - Albania 5
AU - Australia 5
KG - Kirghizistan 5
OM - Oman 5
BG - Bulgaria 4
BY - Bielorussia 4
GH - Ghana 4
GT - Guatemala 4
LB - Libano 4
LV - Lettonia 4
PE - Perù 4
SV - El Salvador 4
AZ - Azerbaigian 3
GE - Georgia 3
PA - Panama 3
PS - Palestinian Territory 3
PT - Portogallo 3
RO - Romania 3
TH - Thailandia 3
BA - Bosnia-Erzegovina 2
CG - Congo 2
GD - Grenada 2
HN - Honduras 2
IR - Iran 2
KW - Kuwait 2
LT - Lituania 2
LY - Libia 2
NO - Norvegia 2
SN - Senegal 2
BH - Bahrain 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
GR - Grecia 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
KR - Corea 1
KZ - Kazakistan 1
LC - Santa Lucia 1
LK - Sri Lanka 1
Totale 16.305
Salva come PNG Salva come JPEG
Città #
Ashburn 1.034
Moscow 973
Dallas 720
Singapore 692
Dublin 691
Chandler 502
San Jose 348
Nyköping 329
Hong Kong 295
Beijing 267
Messina 256
Jacksonville 230
Warsaw 230
Council Bluffs 173
The Dalles 158
Los Angeles 133
Ann Arbor 120
Dearborn 107
Lauterbourg 89
Munich 87
Princeton 83
New York 79
Medford 78
São Paulo 70
Cambridge 62
Des Moines 58
Boardman 57
Houston 56
Ho Chi Minh City 54
Santa Clara 49
Buffalo 43
Helsinki 43
Tianjin 43
Orem 41
Turku 41
Bremen 38
Brussels 37
Frankfurt am Main 35
Jinan 34
Guangzhou 32
Hanoi 32
Redondo Beach 30
Brooklyn 28
Brasília 27
Shenyang 27
Hyderabad 25
Pune 25
Chennai 23
Rome 23
Abidjan 22
Nuremberg 22
Rio de Janeiro 22
Wilmington 22
Belo Horizonte 21
Nanjing 21
Catania 20
Atlanta 19
Phoenix 19
Tokyo 19
Boston 18
Columbus 18
Dong Ket 18
Lancaster 18
San Mateo 18
Shenzhen 18
Woodbridge 18
Amsterdam 17
London 17
Montreal 17
Shanghai 17
Jakarta 16
Denver 15
Haikou 15
Johannesburg 15
Vienna 15
Chicago 14
Tashkent 14
Avola 13
Curitiba 13
Mexico City 13
Zhengzhou 13
Düsseldorf 12
Haiphong 12
Hangzhou 12
Hebei 12
Porto Alegre 12
Seattle 12
Lahore 11
Palermo 11
Stockholm 11
Campinas 10
Manchester 10
Ningbo 10
North Bergen 10
Poplar 10
Taizhou 10
Ankara 9
Baghdad 9
Brno 9
Dhaka 9
Totale 9.465
Salva come PNG Salva come JPEG
Nome #
Acute kidney injury in cirrhotic patients undergoing contrast-enhanced computed tomography 276
Antibody to hepatitis B virus core antigen positivity is a predictor of non-alcoholic fatty liver disease severity 274
PIVKA-II is a useful tool for diagnostic characterization of ultrasound-detected liver nodules in cirrhotic patients 267
Nodular-cystic eruption in course of sorafenib administration for hepatocarcinoma: An unconventional skin reaction requiring unconventional treatment 267
Hepatitis B virus (HBV) DNA integration in patients with occult HBV infection and hepatocellular carcinoma. 264
Atrial fibrillation in patients with cirrhosis 256
Biglycan expression, earlier vascular damage and pro-atherogenic profile improvement after smoke cessation in young people. 251
Evaluation of CTNNB1 and TP53 variability in patients with hepatocellular carcinoma and occult hepatitis B virus infection 247
Scelte terapeutiche e trattamento con sorafenib nell'epatocarcinoma: Analisi finale dello studio GIDEON in Italia 228
Free episomal and integrated HBV DNA In HBsAg-negative patients with intrahepatic cholangiocarcinoma 226
Antioxidant effect of atorvastatin is independent of PON1 gene T(-107)C, Q192R and L55M polymorphisms in hypercholesterolaemic patients 225
The calm before the storm: A report from the International Liver Cancer Association Congress 2015 - Part 1 223
Assessment of liver stiffness in subjects affected by familial combined hyperlipidaemia with hepatic steatosis. 220
Risk Factors Associated with NASH in Obese Patients Undergoing Bariatric Surgery NASH and bariatric surgery 219
Frequency of somatic mutations in TERT promoter, TP53 and CTNNB1 genes in patients with hepatocellular carcinoma from Southern Italy 217
Does the margin width influence recurrence rate in liver surgery for hepatocellular carcinoma smaller than 5 cm? 214
Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study 214
Case Report: Atrial Fibrillation After Intravenous Administration of Iodinated Contrast Medium in a Patient With Hepatocellular Carcinoma 213
Hepatitis B virus and hepatitis C virus co-infection: additive players in chronic liver disease? 211
A 1-year study on hydroxy-methylglutaryl coenzymea reductase gene expression and polymorphisms in hypercholesterolemic treated with statins. 211
NS3 Variability in Hepatitis C Virus Genotype 1A Isolates from Liver Tissue and Serum Samples of Treatment-Naïve Patients with Chronic Hepatitis C 210
ANTIOXIDANT CAPACITY OF CIRCULATING ENDOTHELIAL PROGENITOR CELLS (EPCS) AND CIGARETTE SMOKING 205
Erectile dysfunction in compensated liver cirrhosis 204
Ateromasia carotidea e livelli lipidici in soggetti affetti da DM2: risultati di una analisi retrospettiva 203
Cirrhotic Patients with Bacterial Infection and Negative Cultures Have a More Advanced Disease and an Increased Short-Term Mortality Rate 202
Association between serum paraoxonase (PON1) gene promoter T(-107)C polymorphism, PON1 activity and HDL levels in healthy Sicilian octogenarians 201
C-Reactive Protein (CRP) plasma levels, monocyte MCP-1 (Monocyte Chemoattractant Protein-1) and TF (Tissue Factor) mRNA in patients with primary arterial hypertension 200
Elective endoscopic variceal ligation is not a risk factor for bacterial infection in patients with liver cirrhosis 198
Occult hepatitis B virus infection predicts non-alcoholic steatohepatitis in severely obese individuals from Italy 197
Pulse wave velocity and augmentation index, but notintima-media thickness, are early indicators ofvascular damage in hypercholesterolemic children 191
Biglycan expression is increased in hypertensive subjects with normal or increased carotid intima-media wall thickness 186
Vitamin D Status in Rheumatoid Arthritis: Inflammation, Arterial Stiffness and Circulating Progenitor Cell Number 186
Circulating progenitor cells and the elderly: a seven-year observational study. 183
Mitochondrial DNA is a target of HBV integration 182
Biglycan expression in hypertensive subjects with normal or increased carotid intima-media wall thickness 179
Circulating progenitor cells in rheumatoid arthritis: association with inflammation and oxidative stress. 177
Anatomic variations: a rare variant of formation of the portal vein 177
Rate of hepatocellular carcinoma diagnosis in cirrhotic patients with ultrasound‑detected liver nodules 177
Extracellular superoxide dismutase (EC-SOD) gene mutations screening in a sample of Mediterranean population 175
Over time evaluation of glycaemic control in direct-acting antiviral-treated hepatitis C virus/diabetic individuals with chronic hepatitis or with cirrhosis 173
Hepatitis E virus infection as a cause of acute hepatitis in Southern Italy 169
Hypergammaglobulinemia before Starting DAA Therapy Is A Strong Predictor of Disease Progression in Cirrhotic Patients Even after HCV Clearance 167
Fatty Liver as Potential Biomarker of Atherosclerotic Damage in Familial Combined Hyperlipidemia 165
Hypergammaglobulinemia is a strong predictor of disease progression, hepatocellular carcinoma, and death in patients with compensated cirrhosis. 165
Capacità antiossidante delle cellule progenitrici endoteliali ed abitudine al fumo di sigaretta 164
879 CHOLANGIOPATHY AND HCC IN MDR3 DEFICIENCY 162
The HCV Sicily Network: A web-based model for the management of HCV chronic liver diseases 159
Olmesartan and atorvastatin are effective in improving circulating progenitor cells profile in hypertensive subjects 158
Biglycan expression in hypertensive subjects with normal or increased carotid intima-media wall thickness. 157
Risk of occult hepatitis B virus infection reactivation in patients with solid tumours undergoing chemotherapy 156
Monofocal hepatocellular carcinoma: How much does size matter? 154
Obesity and liver cancer 154
Potenziali indicatori di longevità in una popolazione di anziani siciliani 153
Circulating progenitor cells and high density lipoprotein levels in elderly 152
Pattern of macrovascular invasion in hepatocellular carcinoma 149
The changing scenario of hepatocellular carcinoma in Italy: an update 146
Ficolin-2 Plasma Level Assesses Liver Fibrosis in Non-Alcoholic Fatty Liver Disease 143
CIRCULATING PROGENITOR CELLS AND HIGH DENSITY LIPOPROTEIN LEVELS IN ELDERLY 142
XXI National Congress of the Italian Society for the Study of Arteriosclerosis (SISA) 21–24 November, Perugia, Italy 141
Proposal of model for personalized early adapted cancer screening in people living with HIV: experience of "Gaetano Martino" Hospital University of Messina 140
Fever and rhomboid target lesion in decompensated cirrhosis 140
Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs 138
Maternal and Neonatal Outcomes in Intrahepatic Cholestasis of Pregnancy 135
Identification of extracellular superoxide dismutase, EC-SOD, mutations in a Sicilian population 133
Smoke exposure and circulating progenitor cells: Evidence for modulation of antioxidant enzymes and cell count 133
Hepatitis B virus DNA integration in tumour tissue of a non-cirrhotic HFE-haemochromatosis patient with hepatocellular carcinoma. 132
Tissue factor expression and activity are not increased in peripheral monocytes isolated from uncomplicated hypertensive patients 130
Platelet activating factor-acetylhydrolase (PAF-AH) activity and HDL levels, but not PAF-AH gene polymorphisms, are associated with successful aging in Sicilian octogenarians. 129
Left Ventricular Function in Hypertension: New Insight by Speckle Tracking Echocardiography. 123
Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002-2033: the ITA.LI.CA database 122
Circulating progenitor cells are increased in newly diagnosed untreated hypertensive patients with arterial stiffening but normal carotid intima-media thickness. 121
Long-term virological and clinical evaluation of chronic hepatitis B patients under nucleos(t)ide analogues therapy 116
Integration of hepatitis B virus DNA in chronically infected patients assessed by Alu-PCR. 116
Arterial hypertension as a comorbidity of cirrhosis 115
Oxidative stress and flogosis: The role of endothelial progenitor cells in rheumathoid arthtritis 114
ACUTE KIDNEY INJURY IN CIRRHOTIC PATIENTS UNDERGOING CONTRAST-ENHANCED COMPUTED TOMOGRAPHY 113
PAF-AH gene polymorphisms and carotid atherosclerosis in sicilian hypercholesterolemic subjects 112
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 109
Platelet-activating factor acetylhydrolase is not associated with carotid intima-media thickness in hypercholesterolemic Sicilian individuals 109
Vit d deficiency, depletion of circulating endothelial progenitor cells and impaired arterial stiffness in patients with ra 109
Occult hepatitis B virus infection: an update 106
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma 103
Characteristics and outcome of anti-hepatitis D virus positive patients with hepatocellular carcinoma 99
Surveillance for hepatocellular carcinoma with a 3-months interval in "extremely high-risk" patients does not further improve survival 98
The paraoxonase promoter polymorphism (-107)T > C is not associated with carotid intima-media thickness in Sicilian hypercholesterolemic patients 97
Toll-like receptor 3 and interleukine 1b expression in circulating progenitor cells isolated from patients with rheumatoid arthritis 97
Virological profiles in hepatitis B virus / hepatitis C virus co-infected patients under interferon plus ribavirin therapy. 96
Treatment of the Hepatitis B Virus and Hepatitis C Virus Combined Infection: Still a Challenge for the Hepatologist. 92
The calm before the storm: A report from the International Liver Cancer Association Congress 2015 - Part 2 92
Occult hepatitis B virus and hepatocellular carcinoma. 91
Tissue factor and monocyte chemoattractant protein-1 expression in hypertensive individuals with normal or increased carotid intima-media wall thickness. 90
Tissue Factor and Monocyte Chemoattractant Protein-1 expression in hypertensive subjects with normal or increased carotid intima-media thickness 89
Hepatocellular carcinoma: the point of view of the hepatitis B virus. 89
Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus hepatitis C virus-coinfected patients 86
OCCULT HBV IS HIGHLY PREVALENT IN PATIENTS WITH INTRAHEPATIC CHOLANGIOCARCINOMA AND IT IS DETECTED AS BOTH FREE EPISOMAL AND INTEGRATED DNA 85
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis 81
Predictors of non‐transplantable recurrence in hepatocellular carcinoma patients treated with frontline liver resection 80
Atezolizumab plus Bevacizumab after first-line multikinase inhibitors for advanced hepatocellular carcinoma: The concept of “drug class change” 80
Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitors 78
Effects of the angiotensin II receptor blocker losartan on the monocyte expression of biglycan in hypertensive patients. 77
Totale 15.880
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.922
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.922
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022550 0 0 19 25 27 15 37 23 9 127 87 181
2022/20231.924 140 206 76 154 162 174 24 126 803 10 36 13
2023/2024484 37 79 27 40 32 109 3 22 2 49 21 63
2024/20252.519 30 70 75 154 162 128 95 452 584 159 245 365
2025/20268.325 423 623 619 493 643 1.658 947 1.066 1.091 407 186 169
2026/2027865 240 562 63 0 0 0 0 0 0 0 0 0
Totale 16.587